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Abstract
Cathelicidins are a family of antimicrobial peptides that act as effector molecules of the innate immune system with broad-
spectrum antimicrobial properties. These evolutionary conserved cationic host-defence peptides are integral components
of the immune response of fish, which are generally believed to rely heavily on innate immune defences to invading
pathogens. In this study we showed that Atlantic salmon cathelicidin 1 and 2 (asCATH1 and asCATH2) stimulated peripheral
blood leukocytes increasing the transcription of the chemokine interleukin-8. Further, functional differences were identified
between the two cathelicidins. In the presence of serum, asCATH1 displayed greatly diminished host haemolytic activity,
while the constitutively expressed asCATH2 had no haemolytic activity with or without serum. These findings support our
hypothesis that fish cathelicidins exert their primary antimicrobial action at the site of pathogen invasion such as epithelial
surfaces. Further, we hypothesise that like their mammalian counterparts in the presence of serum they act as mediators of
the innate and adaptive immune response via the release of cytokines thus indirectly protecting against a variety of
pathogens. We highlight the importance of this immunomodulatory role from the involvement of asCATHs during an
infection with the fish pathogen Yersinia ruckeri. While we were able to demonstrate in vitro that asCATH1 and 2, possessed
direct microbicidal activity against the fish pathogen, Vibrio anguillarum, and a common gram negative bacterium,
Escherichia coli, little or no bactericidal activity was found against Y. ruckeri. The contribution of either asCATH in the
immune response or as a potential virulence factor during yersiniosis is highlighted from the increased expression of
asCATH1 and 2 mRNA during an in vivo challenge with Y. ruckeri . We propose that Atlantic salmon cathelicidins participate
in the interplay between the innate and adaptive immune systems via the release of cytokines enabling a more effective
response to invading pathogens.
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Introduction
Cathelicidins are a family of cationic peptides that exert
antimicrobial activity at physiological concentrations and are
thought to be an important component of host immune defence.
These gene-encoded ribosomally synthesised antibiotics are
produced as prepropeptides containing a highly conserved
cathelin-like domain from which they derive their name. The
proteolytic removal of the signal peptide and prosequence yields a
heterogeneous mature peptide [1]. The mature peptides typically
display amphipathic and cationic properties, which aid in bacterial
cell membrane disruption [2]. Initially identified in bovine
neutrophils during the early 1990s [3] cathelicidins have
subsequently been found in a variety of mammals [4]. Once
believed to be mammal-specific peptides, cathelicidin genes have
since been characterised in the ancient vertebrate, the Atlantic
hagfish [5] followed by discovery in rainbow trout [6], chickens
[7], Atlantic salmon [2], and other divergent fish species [8,9,10]
and reptiles [11,12]. Extensive in vitro studies conducted using
mammalian cathelicidins have shown that they possess broad
antimicrobial activities enabling defence against a range of Gram
negative and Gram positive bacteria, fungi, parasites and viruses
[13]. More limited studies performed in vivo demonstrate the
importance of cathelicidins in mammalian defence mechanisms.
The lack of the murine cathelicidin (CRAMP) in CRAMP-
knockout mice increases susceptibility to group A Streptococcus
infections [14]. Likewise the human cathelicidin LL-37 has been
shown to have a protective function against several invasive
bacterial skin infections [15,16]. Further, overexpression of LL-37
in a cystic fibrosis xenograft model increased antimicrobial activity
and bacterial killing [17].
In addition to their predominant antimicrobial role mammalian
cathelicidins possess several other biological activities including the
ability to chemoattract neutrophils, monocytes and T cells [18];
support antisepsis via LPS binding abilities [19], and promote
angiogenesis and wound healing [20][21]. The strong antibacterial
activity, even against multi-drug resistant strains, and immuno-
modulatory properties of cathelicidins make them a popular
candidate for clinical treatments of infection and disease [21].
Although most of these activities have been characterised in
mammals it remains to be seen if cathelicidins of non-mammalian
vertebrates such as fish possess similar capabilities other than their
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fact research on fish cathelicidins has been predominantly limited
to identification, genetic characterisation and tissue expression
studies. Although several of these studies identified antibacterial
and host haemolytic activities of the cathelicidins only a few
investigated expression changes after bacterial infection [22].
While the knowledge of fish cathelicidin functions is limited, the
evolutionary status of fish and their greater dependence on innate
immune mechanisms to prevent microbial infection [23] make
them interesting candidates to study the immune functions of
cathelicidins.
While usually considered beneficial, the expression of cathe-
licidins can also contribute to pathophysiology of diseases.
Cathelicidin LL-37 expression is increased in patients with
psoriasis and rosacea, but decreased in those with atopic
dermatitis. In rosacea, overexpression causes inflammation and
abnormal blood vessel growth through cell activation [24]. In
psoriasis, it is believed that self RNA or DNA forms complexes
with LL-37, which drives auto-inflammatory responses associated
with the disease [25,26]. Similarly low levels of LL-37 in saliva are
associated with periodontal disease [27] and have been implicated
in chronic ulcers [28].
Although humans and mice have a single cathelicidin, the
majority of species possess more than one member of the
cathelicidin family. Recently, xenobiotic transfer of a pig
cathelicidin gene to mouse skin conferred resistance to group A
Streptococcus infection [29]. Based on this finding the authors
proposed that the duplication and divergence of cathelicidins was
beneficial. In Atlantic salmon, two cathelicidin genes have been
identified – asCATH1 and asCATH2 [2]. However, unlike the
rainbow trout cathelicidins rtCATH1 and 2, genetically char-
acterised by Chang et al. [2], and shown to exhibit antimicrobial
activity, neither asCATH1 nor 2 were subject to expression or
functional studies. Therefore, having previously identified the
involvement of a cathelicidin gene from an unpublished cDNA
microarray study of Atlantic salmon challenged with the fish
pathogen Y. ruckeri we decided to further investigate the role that
cathelicidins may play in a non-mammalian species such as
Atlantic salmon in combating bacterial infection.
We show that asCATH2 in contrast to asCATH1 was
constitutively expressed in healthy uninfected Atlantic salmon
and that the expression of both was induced during infection with
Y. ruckeri. Moreover, the potent antimicrobial activity of both
cathelicidins against E. coli and the fish pathogen V. anguillarum was
non-existent when tested against Y. ruckeri. As the constitutively
expressed asCATH2 displayed no host haemolytic activity and the
haemolytic activity of asCATH1 was substantially reduced in the
presence of host serum we hypothesised that cathelicidins have an
immunomodulatory role. We demonstrate that Atlantic salmon
cathelicidins stimulate the expression of the chemokine interleu-
kin-8 and to our knowledge this is the first study demonstrating the
immunomodulatory role of cathelicidins in fish.
Results and Discussion
Differential tissue gene expression of Atlantic salmon
cathelicidins
Constitutive expression was observed for asCATH2 in the range
of organs sampled from healthy Atlantic salmon except the liver.
In contrast asCATH1 was not expressed in any of the tissues
(Fig. 1). Similar to asCATH1 in the present study rtCATH1 was
not detected in any of the tissues analysed until after bacterial
infection [2]. Of the salmonid CATH1 clade members identified
to date only rtCATH1 and brown trout cathelicidin (btrCATH)
tissue expression has been assessed. The btrCATH was constitu-
tively expressed in the anterior and posterior kidney, spleen and
stomach, weakly in the brain and skin, but was absent in the
muscle and testis [10]. Fish cathelicidins that are closely related to
asCATH2 include rtCATH2, Chinook salmon CATH (csCATH),
btCATH2, Arctic charr cathelicidin (acCATH) and the grayling
cathelicidin (gCATH) [10]. Maier et al. [8] observed constitutive
low level expression of acCATH in all tissues tested and Chang
et al. [2] found that rtCATH2 was expressed constitutively in all
tissues, except the liver of healthy rainbow trout. The patterns
observed in fish cathelicidin expression studies show that the
constitutive expression of CATH1 cathelicidins is restricted, while
CATH2 members are more widely expressed.
Cathelicidin expression during bacterial challenge from
Yersinia ruckeri
Yersiniosis is a bacterial disease caused by Yersinia ruckeri, which
was first isolated in Idaho, USA from rainbow trout during the
1950s [30,31]. The disease has caused significant losses of farmed
salmonids worldwide, predominantly in rainbow trout in the
Northern Hemisphere [32]. The Tasmanian serotype O1b of Y.
ruckeri causes yersiniosis in Atlantic salmon, but not in rainbow
trout and brown trout [33]. Having previously identified the
involvement of a cathelicidin gene from an unpublished cDNA
microarray study of Atlantic salmon challenged with Y. ruckeri we
further investigated the role of cathelicidins in yersiniosis.
During yersiniosis, the expression of the genes encoding
asCATH1 and 2 were upregulated in the gills and spleen of
Atlantic salmon. The expression of asCATH2 was upregulated to
a greater extent than asCATH1 in both organs at all time points
post-infection (Fig. 2). Cathelicidin upregulation has been
observed in other fish species after bacterial challenge. Of the
salmonids, the rainbow trout and Arctic charr are the only other
species for which cathelicidin expression has been analysed after a
bacterial challenge. Similar to asCATH1, the expression of
rtCATH1 was considerably upregulated in the gill, spleen and
head kidney of fish 24 h post-infection with Aeromonas salmonicida
[6]. A more variable expression of rtCATH2 was found with an
earlier upregulation detected in the gill and intestine at 8 h post-
infection and a later response at 24 h in the head kidney [2]. Only
a small upregulation of rtCATH2 was detected in the spleen of
infected fish, which is contrary to the observed expression changes
of asCATH2. Overall the relative expression of rtCATH2 was
Figure 1. Expression of asCATH1 and 2 in a range of organs
from a representative healthy juvenile Atlantic salmon. PCR was
performed on cDNA samples from the various organs and 10 ml of each
product was visualised on a 1% LB agarose gel. b-actin was included to
assess the quality and quantity of cDNA.
doi:10.1371/journal.pone.0023417.g001
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asCATH1 and 2. The rainbow trout beta defensins are another
family of AMPs within which different family members exhibit
varied expression changes during an infection. For example, the
beta defensin 3 (omDB-3) was upregulated 16 fold relative to
controls 48 h post-infection with Y. ruckeri compared to omDB-1,
Figure 2. Relative expression of asCATH1 and 2 in the gill (A) and spleen (B) of Atlantic salmon post-infection with Y. ruckeri. Gene
expression was measured by quantitative real-time PCR. Expression at 8, 24, 48, 72 and 96 h post-infection was compared to expression at 0 h. Each
bar represents the mean 6 SE of at least 4 fish sampled at each time point. * indicates a significant upregulation of cathelicidin expression compared
to expression at 0 h (p,0.05, as assessed by one-way analysis of variance and Dunnett’s post-test).
doi:10.1371/journal.pone.0023417.g002
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cathelicidin expression post-infection with A. salmonicida in Atlantic
cod and Arctic charr, both of which showed higher expression at
24 h post-infection compared to uninfected fish, which is
consistent with observations made in this study [8]. No change
in codCATH expression was detected in the spleen, but an
increase was seen in the liver, pyloric caeca, intestine and to a
lesser extent the gill and skin [8]. The acCATH, which is a
member of the salmonid CATH2 clade, gene expression increased
in all tissues, particularly the skin, gill, intestine, spleen and kidney
[8]. At 5 d post-infection acCATH was highly expressed in all
tissues analysed [8], indicating that fish cathelicidin expression
may be prolonged during an infection.
Atlantic salmon cathelicidins exhibited extended upregulation
during yersiniosis. Both genes encoding asCATH1 and 2 were
significantly upregulated at least 96 h post-infection (Fig. 2). The
upregulation of asCATH1 did not vary greatly between 96 and
72 h post-infection suggesting expression had peaked; however the
asCATH2 gene was further upregulated. For example, in the
spleen of infected fish asCATH1 expression was maintained at
approximately 30 fold higher than the expression in control fish at
72 and 96 h. Alternatively, asCATH2 expression more than
doubled in fold increase from 48 fold at 72 h post-infection to 98
fold at 96 h. In rainbow trout, cathelicidin expression was not
analysed beyond 24 h, but rtCATH1 gene expression was highest
at 24 h while rtCATH2 expression was variable among the tissues
[2]. The expression of rtCATH2 was highest in the gill and
intestine at 8 h and had returned to normal levels by 24 h post-
infection, which is contrary to observations made for asCATH2.
However, investigations in Arctic charr, found that acCATH,
another CATH2 group member, was expressed at a high level in
all tissues 5 d post-infection, supporting the notion that the
CATH2 genes are expressed for a prolonged period post-infection.
The codCATHs were also reported to show extended expression
remaining significantly upregulated 72 h post-infection with A.
salmonicida, although expression was much lower than that
observed at 24 h [35].
Both asCATH1 and 2 were upregulated to a greater extent and
earlier in infection in the spleen compared to the gills (Fig. 2).
Other fish AMPs, such as the rainbow trout cathelicidins and b-
defensins, the codCATHs and white bass moronecidin, show
variable tissue expression of peptides during infection [2,34,35,36].
In an experimental infection of rainbow trout high bacterial loads
of Y. ruckeri were detected in the gills immediately after infection
with a rapid spread to internal organs [37]. At 6 h post-infection
the number of bacteria in the spleen peaked, while gill numbers
were highest earlier in infection and bacterial counts decreased
from 6 to 48 h before increasing again to 72 h, more so in the
spleen than gills [37]. Although in rainbow trout, not Atlantic
salmon, the higher bacterial load in the spleen during yersiniosis
could explain the higher expression of the Atlantic salmon
cathelicidins in the spleen compared to the gills.
In addition to prolonged expression, the cathelicidin genes are
upregulated well above the expression levels in normal, uninfected
fish (Fig. 2). The expression of asCATH2 was upregulated as much
as 98 fold higher than normal in the spleen and 43 fold above
normal in the gills of fish infected with Y. ruckeri at 96 h post-
infection. The expression of asCATH1 was upregulated to a lesser
extent, peaking at 30 fold higher in the spleen than controls at 72
and 96 h post-infection and at a maximum of 22 fold in the gills,
which is comparable with expression studies of the Atlantic cod
cathelicidin. At its peak expression the codCATH was upregulated
32 fold compared to 0 h uninfected fish in the spleen and 10 fold
upregulated in the head kidney [35]. Although, studies in mice
have seen the mouse cathelicidin, CRAMP, expressed as much as
1200 fold higher than controls in the lungs of mice 28 d post-
infection during progressive tuberculosis [38], this study suggested
the magnitude of the response may have been due to the high
bacterial load and route of infection (injection of 2.5610
5
Mycobacterium tuberculosis cells). Mammalian studies have reported
cathelicidin expression changes in the order of 2–3 fold increases
as a normal response during bacterial infection compared to
uninfected controls, including the porcine cathelicidins PR-39 and
protegrin [39] and the human cathelicidin LL-37 [21]. Another
group of salmonid AMPs, the rainbow trout beta defensin genes,
were upregulated at a maximum fold increase of 16 times that of
control fish during infection with Y. ruckeri [34].
This study is the first to look at the expression of Atlantic
salmon cathelicidins, and indeed any fish cathelicidin, after
infection with Y. ruckeri. The codCATHs were upregulated in the
gills of cod post-infection with A. salmonicida, but were not
upregulated during infection with V. anguillarum [40], indicating
that the host cathelicidin response is specific to the bacteria
causing the infection. Different strains of Y. ruckeri also vary in
virulence and produce different disease outcomes [37]. The
extent of cathelicidin response seen during yersiniosis may
therefore be specific to the Tasmanian O1b serotype of Y. ruckeri.
Further studies are needed to compare the relative levels of
asCATH1 and 2 expression seen in this study with expression
during infection with other strains of Y. ruckeri as well as other
diseases of Atlantic salmon.
Antibacterial properties of Atlantic salmon cathelicidins
and LL-37
Both asCATH1 and 2 were antimicrobial to V. anguillarum at
relatively low MICs, however neither peptide showed any activity
to Y. ruckeri up to 80 mM (Fig. 3). LL-37 had an MIC of 40–80 mM
to Y. ruckeri, which was much higher than the MICs observed
against V. anguillarum and E. coli (Table 1). Chang et al. [2]
reported an MIC of 8 mM for both rainbow trout cathelicidins
against Y. ruckeri strain MT252. Similarly, both rtCATH1 and 2
were approximately 10 fold more inhibitory towards V. anguillarum
O1 strain (MT1742) than asCATH1 or 2 were to the O1 strain
used in the present study. Interestingly, Chang et al. [2] reported
an MIC of 1 mM against the control strain of E. coli (ATCC 25922)
which was very similar to the MIC of 1.25–2.5 mM we found for
asCATH1 using the identical E. coli strain. The mature
cathelicidin peptides are highly variable, which may explain why
cathelicidins of relatively closely related species within the
salmonidae family, show such variation. The inability to clear
bacteria and thus the continual presence of a stimulus for
expression may explain the prolonged upregulation of the
cathelicidins observed in this study. However, many factors are
involved in immune responses and the pathways by which
cathelicidins are induced and controlled in fish are unknown.
High antibacterial activity is often correlated with haemolytic
activity of cathelicidins [41]. The asCATH1 peptide showed more
potent antimicrobial activity than asCATH2, which corresponded
to the toxicity of the two peptides. When exposed to asCATH1 an
MIC of 1.25–2.5 mM against the control strain of E. coli was
observed, while asCATH2 had a much higher MIC of 10–20 mM.
This variance in antimicrobial activity between peptides is typical
of multi-cathelicidin species, such as the chicken, sheep and
rainbow trout [2,7,42]. The human peptide LL-37 displayed
similar antimicrobial activity to E. coli as asCATH1 with an MIC
of 0.63–1.25 mM, which is close to previously reported MICs for
LL-37 to the ATCC 25922 strain of E. coli (0.1–0.8 mM) [43].
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LL-37
Typical signs of yersiniosis in Tasmanian farmed Atlantic
salmon include haemorrhaging around the pectoral and pelvic
fins, blood spots in the eyes and hypertrophy of the spleen [33].
Other cathelicidins are haemolytic to host erythrocytes and
cytotoxic to other cell types [41,44], thus in an attempt to reveal
possible reasons behind the extensive haemorrhaging that occurs
during yersiniosis we investigated the haemolytic activity of
asCATH1 and 2. asCATH2 showed no haemolytic activity to
Atlantic salmon erythrocytes, while asCATH1 and LL-37 were
haemolytic to Atlantic salmon erythrocytes (Fig. 4). asCATH1
caused haemolysis of Atlantic salmon erythrocytes at concentra-
tions as low as 1.24 mM, where haemolysis was 7.54%, and up to
58% haemolysis at higher concentrations. In contrast the
haemolytic activity of asCATH1 and LL-37 was absent in the
presence of Atlantic salmon serum at all concentrations apart from
the highest. Even at the highest concentration of 300 mM the
haemolytic activity of asCATH1 and LL-37 was dramatically
reduced from 58% to 4% and 60% to 10%, respectively.
rtCATH1, which belongs to the salmonid CATH1 clade, caused
only 2% haemolysis at 256 mM and less than 10% haemolysis at
concentrations as high as 2560 mM [6]. Differences in the
haemolytic activity of cathelicidin family members have been
observed in sheep where SMAP-29 was more haemolytic than
SMAP-28 [41,44]. The difference in haemolytic activity between
asCATH1 and 2 may be due to the structural differences in the
Figure 3. Antibacterial activity of asCATH1 and 2 against three species of bacteria - Y. ruckeri (A), V. anguillarum (B) and E. coli (C).
Bacteria were grown to mid-log phase then incubated for 18 h with varying concentrations of the Atlantic salmon cathelicidins. LL-37 was included as
a control for bacterial killing and E. coli ATCC 25922 was included as a control bacterium. Absorbance was read at 600 nm and percentage growth
was calculated by comparison to the no inhibition control lane in the assay. The MIC was defined as 50% inhibition, which is indicated by a dotted
line on each plot. Data shown are the mean 6 SE of triplicate wells.
doi:10.1371/journal.pone.0023417.g003
Table 1. Antibacterial activity of asCATH1 and 2.
Bacteria asCATH1
MIC (mM)
asCATH2 LL-37
Y. ruckeri .80 .80 40–80
V. anguillarum 5–10 10–20 0.63–1.25
E. coli (ATCC 25922) 1.25–2.5 10–20 0.63–1.25
Bacteria were incubated with varying concentrations of cathelicidin peptides
for 18 h before absorbance was read at 600 nm to determine bacterial growth.
MIC values are shown as the range of concentrations which produced a 50%
reduction in growth compared to a control without cathelicidin.
doi:10.1371/journal.pone.0023417.t001
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salmonid CATH1 and CATH2 mature peptides, respectively.
Cathelicidins are amphipathic in nature and cause cell lysis by
destabilising membranes and subsequent cell rupture. A stronger
electrostatic interaction with prokaryotic membranes than eukary-
otic makes cathelicidins selective in killing bacteria rather than
damaging self-cells [41,45]. Basan ˜ez et al. [45] demonstrated this
with the hagfish cathelicidins, which associated with model bacterial
membranes to a much greater extent than erythrocyte membranes.
However, mechanisms other than the electrostatic interaction
between peptide and membrane are involved in conferring
selectivity of non-self, for instance membrane composition and
additional properties of the peptide such as hydrophobicity [46]. In
this study the peptide-membrane interaction between asCATH1
and Atlantic salmon erythrocytes creates membrane instability that
was observed as haemolysis in the haemolytic assay. Therefore,
asCATH1 possibly contributes to the signs of yersiniosis in Atlantic
salmon through its potential cytolyticactions. Interestingly,we found
that serum from Atlantic salmon blood inhibited the haemolytic
activityofasCATH1suggesting thathaemolyticactivityisunlikelyto
occur in vivo and that potential cytolytic activity would be limited to
tissues and serum-free epithelial surfaces. Similarly, in vitro tests of
other cathelicidins have shown that serum inhibits haemolytic/
cytotoxic and antibacterial activity [47,48]. While we demonstrated
thathaemolyticactivitywasreduced inthe presenceofserum further
research is required to assess the potential inhibitory effect of serum
on the antibacterial activity of asCATH1 and 2 peptides.
Host immunomodulatory activities of Atlantic salmon
cathelicidins
Despite showing no inhibition of Y. ruckeri in the broth micro-
dilution assay, asCATH1 and 2 were significantly upregulated
during the immune response in yersiniosis – up to 98 fold higher
than expression observed in uninfected fish (Fig. 2). The
expression of asCATH1 was significantly less than asCATH2 in
response to Y. ruckeri and showed a more restricted constitutive
expression profile in the organs tested in this study. This
differential expression may help protect the host from the potential
cytolytic effects of asCATH1. Furthermore, asCATH1 showed
haemolysis at concentrations as low as 1.24 mM, a concentration
that is reasonable to expect in vivo. The human cathelicidin LL-37
is maintained at a physiological concentration of approximately
0.44 mM( 2mg/mL) [21,49,50]. Thus if asCATH1 is present at a
similar physiological concentration as LL-37, a 3 fold increase in
peptide expression is all that is needed to reach a haemolytic
concentration. However, asCATH2 showed no haemolysis and
less antibacterial activity than asCATH1. Therefore the question
arises as to what function does the increased expression of
asCATH2 fulfil? Recent mammalian studies provide convincing
evidence that some AMPs do not simply kill microbes but
indirectly confer protection by modulating the immune system
[24,51,52,53]. Likewise, we demonstrate that both asCATH1 and
2 stimulated the increased expression of the chemokine interleu-
kin-8 (IL-8) in peripheral blood leukocytes (PBLs). To investigate
the influence of asCATH1 and 2 on cytokine production we
stimulated PBLs for 16 h with varying concentrations of the
peptides and measured transcriptional changes in interleukin-1 b
(IL-1 b), interleukin-18 (IL-18), and IL-8 expression, of which the
latter has been reported to be regulated by cathelicidins in humans
[21,54]. IL-8 expression was significantly upregulated at either 5
or 8 h post-stimulation at all concentrations (2.5 mM, 5 mM,
10 mM) but was greatest (4–5 fold) in PBLs stimulated with 10 mM
asCATH1 (Fig. 5). The increased IL-8 mRNA expression was
transient as it was reduced to levels deemed biologically
Figure 4. Haemolytic activity of the Atlantic salmon cathelicidins to Atlantic salmon erythrocytes. Erythrocytes were incubated with
varying concentrations of the cathelicidins for 2 h and the absorbance of the well supernatants was read at 405 nm to detect released haemoglobin. Per-
centage haemolysis was calculated from 100% lysiscontrols, which were incubated with 0.2% Triton-X100. Data shownare the means 6SDof duplicatewells.
doi:10.1371/journal.pone.0023417.g004
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asCATH1 (A,C,E) and asCATH2 (B,D,E). Gene expression was assessed by real-time PCR at 0, 2, 5, 8 and 16 h post incubation with asCATH1 or
asCATH2 at 2.5 mM (A,B), 5 mM (C,D) and 10 mM (E,F). Expression was normalised to the mean expression of four stable reference genes. Data shown
are the means 6 SE of quadruplicate PBL samples assayed in duplicate by quantitative real-time PCR and presented as fold induction compared to
0 h. * indicates a significant fold induction (P,0.05) compared to 0 h while the dotted line represents the minimum fold change (2 fold) deemed
biologically significant.
doi:10.1371/journal.pone.0023417.g005
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with asCATH1 at 10 mM. Furthermore, neither asCATH was
found to differentially regulate the expression of the pro-
inflammatory cytokines IL-1 or IL-18. The transient and specific
stimulation of the chemokine IL-8 supports the argument that
asCATHs likely act to signal the recruitment of immune cells via
IL-8 to the site of infection to help resolve the infection. These
immunomodulatory properties of cathelicidins are of particular
interest in current mammalian research for use as templates in the
design of future antibiotics or adjuvants for vaccination [49,55,56].
Thus the development of artificial analogues of these natural
peptides will be invaluable not only for mammalian use, but also in
aquaculture as potential adjuvants for vaccines.
In summary, we demonstrated that asCATH2 in contrast to
asCATH1 was constitutively expressed in healthy uninfected
Atlantic salmon and showed that the expression of both was
induced during infection with Y. ruckeri. Interestingly, the potent
antimicrobial activity of both cathelicidins against E. coli and the
fish pathogen V. anguillarum was non-existent when tested against
Y. ruckeri. Furthermore, we discovered that the constitutively
expressed asCATH2 displayed no host haemolytic activity and
that the haemolytic activity of asCATH1 was substantially reduced
in the presence of host serum. Further supporting the potential
multifaceted biological roles of these cathelicidins, especially the
constitutively expressed asCATH2, is our finding that asCATH1
and asCATH2 up-regulated the expression of the chemokine
interleukin-8 and thus possibly promoted cell migration to the site
of infection. This property is in addition to the direct antimicrobial
abilities of asCATH1 and asCATH2 and suggests that cathe-
licidins perform an elaborate role in combating infection and one
that possibly circumvents pathogen resistance by effectively
utilising the increasingly important relationship between the
innate and adaptive immune systems.
Materials and Methods
Ethics statement
All animal work was performed in strict accordance with the
Australian Code of Practice for the Care and Use of Animals for
Scientific Purposes and was approved by the University of Tasmania
Animal Ethics Committee (AEC permit number: A0010335).
Fish husbandry and sampling
Atlantic salmon (Salmo salar) parr weighing 4–5 g were obtained
from a local hatchery (SALTAS, Wayatinah, Tasmania, Australia)
and maintained in a semi-recirculating freshwater system at 15uC.
Fish were euthanized and tissue dissected from the gill, spleen,
anterior kidney, posterior kidney, liver, intestine, pyloric caeca,
heart, skeletal muscle, brain, and stored in an RNA preservation
reagent (25 mM sodium citrate, 10 mM EDTA, 10 M ammonium
sulphate, pH 5.2) at 220uC until use.
Constitutive expression of Atlantic salmon cathelicidin
genes
Total RNA was extracted from tissue stored in an RNA
preservation reagent and purified using TRI Reagent (Molecular
Research Center, OH, USA) including DNAse treatment (Turbo
DNase, Ambion, TX, USA). First strand cDNA was synthesised
from total RNA (1 mg) using BioScript reverse transcriptase
(Bioline, NSW, Australia) with Oligo (dT)18 priming according
to manufacturer’s instructions. asCATH1 and asCATH2 were
amplified by PCR to detect expression of the cathelicidins in
cDNA from a range of organs from uninfected Atlantic salmon.
Primers were designed using Primer Premier 5.0 design software
(Biosoft International, CA, USA) from the asCATH1 and 2
sequences published in GenBank with accession numbers
AY728057 and AY360357, respectively. The housekeeping gene
b-actin was also amplified to assess the quality and allow semi-
quantitative analysis of the cDNA samples. All PCR reactions
were performed in 20 ml reaction volumes using Immomix
(Bioline), 0.5 ml forward primer (10 mM), 0.5 ml reverse primer
(10 mM) and 7 ml water. The PCR reactions were run for 35 cycles
using the quantitative real-time PCR (qPCR) cycling protocol
described below and visualised on a 1% lithium borate agarose gel
containing Gel Red dye (Biotium, CA, USA) under UV light.
Bacterial challenge and cathelicidin expression
Fish were challenged with bacteria by 1 h bath exposure to
1610
7 cfu/mL of Yersinia ruckeri strain TCFB 2282. At various
time points post-infection (0, 8, 24, 48, 72 and 96 h) 6 fish were
euthanized and gills and spleen were sampled and stored in RNA
preservation reagent at 220uC until use. Quantitative real-time
PCR (qPCR) was performed on cDNA reverse-transcribed from
total RNA as described above from gill and spleen samples from
fish at different time points post-challenge and used to analyse
changes in asCATH1 and 2 expression over time. The relative
expressions of asCATH1 and 2 were measured by qPCR using
SYBR Green chemistry using an iQ5 Real-time PCR Detection
System (Bio-Rad, NSW, Australia). Table 2 lists the primers for
asCATH1 and 2 detection and of the four reference genes - b-
actin, RNA polymerase 2 (RPL2), polyubiquitin (PolyUb) and
elongation factor 1a (EF1a). qPCR reactions consisted of 20 ml
volumes using a 26SensiMixPlus SYBR & Fluorescein PCR
master mix (Bioline), forward and reverse primers (200 nM of
each) and 2 ml of cDNA. Each gene was assayed in duplicate and a
five step, four-fold dilution series of a pool of cDNA from all
samples was included on the same plate to calculate amplification
efficiencies. The amplification program was as follows: 95uC for
10 min to activate the DNA polymerase followed by 40 cycles of
95uC for 10 s, 55uC for 15 s and 72uC for 15 s. At the end of the
cycling protocol melt curve analysis was run to ensure amplifica-
tion specificity. mRNA expression levels were normalised using the
mean expressions of the four reference genes, which maintained
stable expression, as determined by the geNorm software [57].
The qPCR data were analysed with qBase software as described
[58]. A one-way analysis of variance (ANOVA) with Dunnett’s
post-test was used to compare the expression of asCATH1 or 2 in
the gill and spleen at each time point post-infection to a control
group (0 h samples). All statistics were performed in SigmaPlot
11.0 (Systat Software, CA, USA) with a P value ,0.05 indicating
significant increases in gene expression. Data was graphed using
SigmaPlot 11.0 and rescaled so that the MNRQ of the 0 h group
was equal to 1 and therefore the other time points were presented
as a fold increase compared to 0 h. As the data were rescaled, the
standard errors were propogated as described by [59]).
Peptide synthesis
Two peptides, referred to as asCATH1 and asCATH2,
corresponding to the first 36 amino acids of each mature peptide
of the previously reported Atlantic salmon cathelicidins [2] were
chemically synthesised by Auspep (Tullamarine, Victoria, Aus-
tralia). Residues 145 to 180 of the S. salar cathelicidin (acc. #:
AAW55907) was referred to as asCATH1 (RRSQARKCSRGN-
GGKIGSIRCRGGGTRLGGGSLIGR) and had a molecular
weight of 3685. Residues 150 to 185 of the S. salar cathelicidin-
derived antimicrobial peptide 2 precursor (acc. #: AAT44537)
was referred to as asCATH2 (RRGKPSGGSRGSKMGSKD-
SKGGWRGRPGSGSRPGFG) and had a molecular weight of
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with those of a mammalian cathelicidin the extensively researched
LL-37 peptide was also synthesized. The LL-37 peptide corre-
sponded to residues 134 to 170 (LLGDFFRKSKEKIGKEFK-
RIVQRIKDFLRNLVPRTES) of the sole human cathelicidin
known as cationic antimicrobial protein 18 (hCAP18, acc. #:
NP_004336) and had a molecular weight of 4493. Certificates of
analysis provided with each peptide displayed HPLC chromato-
gram and mass spectral analysis identifying the purity of each
peptide– asCATH1 (86%), asCATH2 (97%) and LL-37 (90%).
Bacteria and culture conditions
Three species of bacteria were used to test the antibacterial
activities of the two Atlantic salmon cathelicidins. The Tasmanian
O1b serotype of Y. ruckeri (UTYR 001A), Vibrio anguillarum serotype
O1 (UTVA 001) and Escherichia coli (ATCC 25922) were
maintained on tryptic soy agar plates until use. Individual
bacterial colonies were selected from the plates and transferred
to 4 mL of Mueller-Hinton broth (MHB). The bacteria were
grown for 2–3 h on a shaker at 20uC until they reached mid-log
phase. 1 mL of the log-phase suspension was centrifuged at 1,000
xg for 5 min at room temperature and the bacterial pellet was
resuspended in 1 mL of one quarter strength (0.25x) MHB. The
suspension was diluted 1:1000 by adding 10 ml to 10 mL of 0.25x
MHB to give a final working suspension of approximately 10
5 cfu/
mL. 100 ml of each of a tenfold dilution of the 1:1000 working
suspension (1/10, 1/100 and 1/1000) was spread onto Mueller-
Hinton agar plates to count colony forming units (cfu).
Antimicrobial and haemolysis assays
A broth microdilution assay was used to measure the
antibacterial activity of the Atlantic salmon cathelicidins as
previously described [60]. Briefly, each peptide was serially diluted
in sterile water to give final concentrations of 800, 400, 200, 100,
50, 25, 12.5 and 6.25 mM. To each well of a flat bottom 96 well
polystyrene microtitre plate 90 ml of the 1:1000 bacterial
suspension was added. 10 ml of the peptide dilutions were then
added to the wells in triplicate so that final peptide concentrations
were 80, 40, 20, 10, 5, 2.5, 1.25 and 0.63 mM. Controls were also
included in the assay: 10 ml of ampicillin (1 mg/mL) was added to
one lane as a control for bacterial killing; a no-inhibition control
contained bacterial suspension with 10 ml of water; and a no-
growth control contained 100 ml of 0.25x MHB only. Plates were
incubated at 20uC for 18 h then absorbances were read at
600 nm. Bacterial growth in wells containing peptide was
compared to the no-inhibition control wells (considered 100%
growth) to determine the MIC of each peptide. The MIC was
defined as the lowest concentration of peptide that reduced
bacterial growth by more than 50% compared to control wells
[2,6,61].
The haemolytic activities of the Atlantic salmon cathelicidins
were assessed as described [6,62]. Briefly, 2 mL of heparinised
whole blood was collected from uninfected Atlantic salmon and
centifuged at 1,000 xg for 10 min at room temperature. The
serum and buffy coat were removed from the tube and discarded.
Erythrocytes were then washed in 1 mL of PBS three times,
centrifuging at 1,000 xg for 10 min and discarding supernatant
between washes. The final pellet was resuspended to 10
8 cells/mL
in PBS or Atlantic salmon serum to assess the effect of serum on
the haemolytic activity. Atlantic salmon serum was obtained from
whole blood left to clot overnight at 4uC, centrifuged at 3,000 xg
for 15 min at 4uC to remove any residual cells, before 0.2 mM
filtration. Each peptide was serially diluted in 1x PBS to give
concentrations of 3000, 1000, 333.3, 111.1, 37, 12.4, 4.1 and
1.4 mM. 180 ml of the erythrocyte suspension was added to the
desired wells of a V-shaped 96 well microtitre plate. 20 ml of each
concentration of the cathelicidin peptides was added to wells in
duplicate, such that the final peptide concentration was tenfold less
than the starting. 20 ml of 2% Triton-X 100 or PBS was added to
the control wells for 100% and 0% lysis, respectively. The plates
were incubated for 2 h at 18uC then centrifuged for 10 min at
1,000 xg. 100 ml of the supernatant from each well was transferred
to a fresh flat-bottom microtitre plate and the optical density was
measured at 405 nm. Percentage haemolysis was determined
for each concentration of peptide by comparison to 100% and
0% lysis using the following formula: [(ACathelicidin –A 0% lysis)/
(A100% lysis –A 0% lysis)]6100, where A is the absorbance at 405 nm.
Peripheral blood leukocyte (PBL) stimulation
Heparinised whole blood from uninfected Atlantic salmon was
diluted 1:1 with 1x HBSS. A discontinuous Percoll gradient was
prepared using Percoll – 1.07 g/mL (49% Percoll) and 1.05 g/mL
(34%). Diluted blood was layered onto the Percoll gradient and
centifuged at 2,000 xg for 20 min at 4uC. Two bands of cells were
removed; one from the serum-34% interface and one from the
34%–49% interface. The collected bands were relayered onto a
fresh 34/49% gradient and centifuged at 800 xg for 10 min at 4uC
to remove residual erythrocytes. A clear band was removed from
the 34%–49% interface and diluted 1:1 with 1xHBSS. The cells
were centrifuged at 500 xg for 5 min at 4uC, the supernatant was
decanted and cells were resuspended in 1x HBSS. Cells were
counted and 100 ml of the cell suspension was also used for a
Table 2. Oligonucleotide primers used in real-time pcr experiments.
Target mRNA Accession # Forward primer (59R39) Reverse primer (59R39)
asCATH1 AY728057 CTTAATTGGTCGCCTG ACGTTGATCTGTGATAAAT
asCATH2 AY360357 TGGCAACACCCTCAA GAATCTTTACTACCCATCT
b-actin AF012125 TTGCGGTATCCACGAGAC TAGAGGGAGCCAGAGAGG
RPL2 BT056485 TAACGCCTGCCTCTTCC ATGAGGGACCTTGTAGCC
PolyUb BT049644 TCTTCATCTGGTCCTGC AATGGGTGGGATTGGAGG
EF1a AF321836 TGATTGTGCTGTGCTTA AACGCTTCTGGCTGTAGG
IL-8 BT046706 ACCAGCGAGATAACAA CCAGGAGCACAATGACAA
IL-1 AY617117 AACTAAGGACTGAATA GAGGTGTTCTTTATTAAAC
IL-18 BT125392 AACGGAATAAGGAGCT TGATGTCACAGAGAGAAT
doi:10.1371/journal.pone.0023417.t002
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leukocytes (PBLs).
PBLs were centrifuged at 350 xg for 5 min and resuspended to a
final concentration of 1610
7 cells/mL in L-15 culture media
containing L-glutamine and 2% Atlantic salmon serum. Peptides
were serially diluted in 1xPBS to give final concentrations of 110,
55, 27.5 and 13.75 mM. To each well of a flat bottom 96 well
microtitre plate 100 ml of cells in media was added, so that there
were approximately 1610
6 cells per well. 10 ml of each peptide
concentration was added in quadruplicate (giving final well
concentrations of 10, 5, 2.5 and 1.25 mM for asCATH1 and 2)
for four different sampling time points (2, 5, 8 and 16 h) after
peptide addition. No-stimulation controls were included for each
time point, with 10 ml of PBS instead of peptide. A 0 h sample was
taken directly before plate incubation by adding 110 mlo f2 x
Tissue and Cell (T&C) lysis solution (Epicentre, WI, USA) to four
wells containing cells with PBS. The cells were mixed with the
T&C lysis solution before being transferred to a 1.5 mL
microcentrifuge tube. 1 mL of Tri-reagent (Molecular Research
Center) was added to each tube and samples were vortexed then
frozen at 270uC until use. Four samples of cells were taken for
each concentration of peptide in the same way after 2, 5, 8 and
16 h incubation at 18uC. Total RNA was extracted, reverse
transcribed and cDNA analysed by qPCR as previously described
using primers specific for interleukin-1(IL-1), interleukin-8 (IL-8)
and interlukin-18 (IL-18) (Table 2).
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